Sarah Fischer is an associate in the firm’s IP Litigation Department. She joined Goodwin in 2015.

Ms. Fischer focuses her practice on patent matters, including biotechnology, pharmaceuticals, medical devices, and software. Ms. Fischer’s experience includes representation of clients in district court litigation and before the Patent Trial and Appeal Board (PTAB). Her practice also includes representing a wide variety of clients, including both plaintiffs and defendants in district court patent proceeding and petitioners and patent owners in PTAB proceedings.

Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围
Scientific Experience

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Ms. Fischer’s experience includes:

  • Shire Development LLC v. Actavis Laboratories FL, Inc. (D. Del.): Representing Actavis in a patent infringement litigation filed by Shire involving formulations of mixed salts of a single-entity amphetamine. The case is currently pending.
  • In re: Copaxone 775 Patent Litigation (D. Del.): Representing Teva in patent infringement litigation against multiple generic defendants involving patents directed to a process for manufacturing glatiramer acetate (Copaxone®). This case is currently pending.
  • Incyte Corp. v. Concert Pharmaceuticals, Inc. (P.T.A.B.): Representing Concert in IPR matter involving deuterated analogs of ruxolitinib. This matter is currently pending.
  • Pfizer Inc. v. Micro Labs USA Inc. (D. Del.): Representing Sun in patent infringement litigation filed by Pfizer involving extended release tofacitinib. This case is currently pending.
  • In re: Copaxone 40mg Consolidated Cases (D. Del.): Representing Teva in a patent infringement litigation against five generic manufacturers involving patents directed to the treatment of multiple sclerosis with a novel dosing regimen for the drug glatiramer acetate. The case is on appeal to the U.S. Court of Appeals for the Federal Circuit.
  • Tris Pharma Inc. v. Actavis Laboratories FL, Inc. (D. Del.): Represented Acavtis in victory over Tris Pharma in federal court in Delaware, paving the way for Actavis to launch a generic version of Quillivant XR® (methylphenidate hydrochloride), a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The Court found invalid five patents covering Quillivant®’s formulation and use, which would have protected the drug from generic competition for another 14 years.
Professional Activities

Ms. Fischer serves on the board of the Massachusetts LGBTQ Bar Association and is a member of the Boston Bar Association.

Professional Experience

Following law school, Ms. Fischer served as a law clerk to the Honorable Ron Clark, Chief Judge of the U.S. District Court for the Eastern District of Texas.

Recognition

Ms. Fischer graduated first in her class at Suffolk University Law School in 2013, where she was awarded the Daniel J. Fern Award for achieving the highest cumulative GPA in her class. She also received a Concentration in International Law with Distinction. While in law school, Ms. Fischer served as an articles editor for the Suffolk University Law Review. She is the author of “Yours, Mine or Ours: A Proposal for Sensible Reform of the Massachusetts Tenancy-by-the-Entirety Statute”, Note, 46 Suffolk U. L. Rev. 1133 (2013). Ms. Fischer was a member of Suffolk University Law School’s Jessup International Moot Court Team and Foreign Direct Investment Moot Team. She won the Suffolk Transnational Law Review International Moot Court Competition in both 2012 and 2013.

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 2013
Suffolk University Law School

(summa cum laude)

M.A., Chemistry, 2010
Boston University
B.S., Chemistry, 2005
University of Massachusetts, Lowell

(summa cum laude)

Clerkships

2013 to 2015 U.S. District Court for the Eastern District of Texas, Honorable Ron Clark

Admissions

Bar

Massachusetts
New York
U.S. Patent and Trademark Office (USPTO)

Courts

U.S. District Court for the Eastern District of Texas
Get In Touch
German Translation
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师